Literature DB >> 6726573

Gastrografin treatment of intestinal obstruction due to Ascaris lumbricoides.

J A Bar-Maor, J L de Carvalho, J Chappell.   

Abstract

Gastrografin was used to relieve subacute intestinal obstruction due to Ascaris lumbricoides in children. This hyperosmolar and wetting agent proved to be highly efficient to achieve this goal. Statistical evaluation of the hospital stay and first bowel action showed a significant difference between the treated "gastrografin group' and the untreated by gastrografin "control group,' in favor of the "gastrografin group.' Our data strongly suggest the use of Gastrografin in subacute intestinal obstruction due to Ascaris lumbricoides. This treatment should be instituted provided the patient has been adequately hydrated prior to administration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726573     DOI: 10.1016/s0022-3468(84)80442-x

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Use of gastrografin in the management of worm-induced small bowel obstruction in children.

Authors:  Raashid Hamid; Nisar Bhat; Aejaz Baba; Gowhar Mufti; Sheikh Khursheed; Sajad A Wani; Imran Ali; Faheem Hassan
Journal:  Pediatr Surg Int       Date:  2015-10-01       Impact factor: 1.827

2.  Role of water soluble contrast agents in assigning patients to a non-operative course in adhesive small bowel obstruction.

Authors:  Hamid Ai Wadani; Naif Ibrahim Al Awad; Khairi Ahmed Hassan; Hazem Mohamed Zakaria; Faten O Alaqeel
Journal:  Oman Med J       Date:  2011-11

3.  Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial.

Authors:  Hok-Kwok Choi; Kin-Wah Chu; Wai-Lun Law
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

4.  Conservative treatment for round worm intestinal obstruction.

Authors:  A N Gangopadhyay; Vijai D Upadhyaya; D K Gupta; S P Sharma; Vijayendra Kumar
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.